ˇ
R. Sebesta et al.
FULL PAPER
OCHCHO), 3.99 (m, 1 H, PhCH) ppm. 13C NMR (75 MHz, CH2NO2), 4.78 (m, 1 H, PhCH2), 4.66 (m, 1 H, PhCH2), 4.58 (m,
CDCl3): δ = 202.7 (CHO), 200.3 (CHO), 136.6 (CAr), 136.4 (CAr),
135.3 (CAr), 134.2 (CAr), 128.5 (CAr), 84.1, 82.6 (CHCHO), 76.3,
1 H, CH2NO2), 4.53 (m, 1 H, CHCHO), 4.06 (m, 1 H, ArCH)
ppm. 13C NMR (300 MHz, CDCl3): δ = 202.0, 200.2 (CHO), 138.2
76.2 (CH2NO2), 74.0, 73.5 (PhCH2O), 45.3, 44.8 (PhCH) ppm. (CAr), 136.0 (CAr), 129.6 (CAr), 128.7 (CAr), 128.6 (CAr), 128.4
HRMS: calcd. for C17H16NO4 [M – H]– 298.108; found 298.079.
HPLC (AD-H, iPrOH/n-hexane = 5:95, 1 mL/min, λ = 217 nm): tR
= 71.2 (syn-minor), 60.8 (syn-major), 46.7 (anti-major), 43.6 (anti-
minor) min.
(CAr), 125.9 (CF3), 83.7, 82.2 (CHCHO), 76.0, 75.2 (CH2NO2),
74.0, 73.7 (CH2O), 44.8, 44.3 (ArCH) ppm. HRMS: calcd. for
C18H15F3NO4 [M – H]– 366.095; found 366.095. HPLC (Chiralpak
AD-H, iPrOH/n-hexane = 5:95, 0.8 mL/min, λ = 217 nm): tR
=
64.8 (syn-minor), 51.8 (anti-minor), 33.2 (anti-major), 24.5 (syn-
major) min.
4-Nitro-3-phenyl-2-(phenyloxy)butanal (10): 1H NMR (300 MHz,
CDCl3): δ = 9.61, 9.40 (d, J = 1.8 Hz, 1 H, CHO), 7.34 (m, 8 H,
Ph), 6.88 (m, 2 H, Ph), 5.00, 4.98 (dd, J = 8.1, 13.5 Hz, 1 H,
CH2NO2), 4.83–4.87 (m, 1 H, CHCHO), 4.79 (dd, J = 7.1, 13.4 Hz,
1 H, CH2NO2), 4.15–4.20 (m, 1 H, PhCH) ppm. 13C NMR
(75 MHz, CDCl3): δ = 201.8, 199.7 (CHO), 129.4 (CAr), 122.8
(CAr), 115.4 (CAr), 82.5, 81.0 (CHCHO), 75.8 (CH2NO2), 45.2, 44.8
(PhCH) ppm. HRMS: calcd. for C16H14NO4 [M – H]– 284.092;
found 284.065. HPLC (Chiralpak AD-H, iPrOH/n-hexane = 5:95,
1 mL/min, λ = 217 nm): tR = 41.9 (syn-minor), 39.0 (anti-minor),
36.1 (syn-major), 33.6 (anti-major) min.
2-(4-Methoxybenzyloxy)-4-nitro-3-phenylbutanal (11): 1H NMR
(300 MHz, CDCl3): δ = 9.48, 9.37 (d, J = 1.6 Hz, 1 H, CHO), 7.28
(m, 5 H, Ph), 6.89 (m, 4 H, MeOPh), 4.82 (dd, J = 8.4, 13.1 Hz, 1
H, CH2NO2), 4.68 (dd, J = 5.2, 12.7 Hz, 1 H, PhCH2O), 4.61 (dd,
J = 4.0, 9.0 Hz, 1 H, PhCH2O), 4.46 (dd, J = 11.3, 17.0 Hz, 1 H,
CH2NO2), 4.06 (dd, J = 1.5, 4.3 Hz, 1 H, CHCHO), 3.96 (m, 1 H,
PhCH), 3.81 (s, 3 H, OCH3) ppm. 13C NMR (75 MHz, CDCl3): δ
= 202.7, 200.2 (CHO), 159.8 (CH3OCAr), 135.2 (CAr), 134.0 (CAr),
129.2 (CAr), 114.1 (CAr), 83.5, 82.1 (CHCHO), 76.3, 76.2
(CH2NO2), 73.5, 73.0 (CH2O), 55.3 (OCH3), 45.1, 44.7 (PhCH)
ppm. HRMS: calcd. for C18H18NO5 [M – H]– 328.119; found
2-(Benzyloxy)-3-(4-chlorophenyl)-4-nitrobutanal (21): 1H NMR
(300 MHz, CDCl3, 23 °C): δ = 9.55, 9.44 (d, J = 1.9 Hz, 1 H,
CHO), 7.25 (m, 9 H, HAr), 4.88 (dd, J = 4.7, 8.5 Hz, 1 H,
CH2NO2), 4.76 (dd, J = 1.5, 3.9 Hz, 1 H, PhCH2O), 4.69 (m, 1 H,
PhCH2), 4.52 (dd, J = 11.5, 15.8 Hz, 1 H, CH2NO2), 4.07 (dd, J =
1.4, 4.15 Hz, 1 H, CHCHO), 3.99 (m, 1 H, PhCH) ppm. 13C NMR
(300 MHz, CDCl3): δ = 202.2, 200.2 (CHO), 132.5 (ClCAr), 128.4–
129.5 (CAr), 83.8, 82.2 (CHCHO), 76.1, 75.6 (CH2NO2), 73.9, 73.6
(CH2O), 44.5, 43.9 (PhCH) ppm. HRMS: calcd. for C17H15ClNO4
[M – H]– 332.069; found 332.069. HPLC (Chiralpak AD-H, iP-
rOH/n-hexane = 5:95, 0.8 mL/min, λ = 217 nm): tR = 71.5 (syn-
minor), 54.4 (anti-minor), 36.6 (anti-major), 32.9 (syn-major) min.
2-(Benzyloxy)-4-nitro-3-(thiophen-2-yl)butanal (22): 1H NMR
(300 MHz, CDCl3): δ = 9.57, 9.48 (d, J = 1.9 Hz, 1 H, CHO), 7.37
(m, 5 H, Ph), 7.25 (m, 1 H, Hthio), 6.97 (m, 1 H, Hthio), 6.93 (m, 1
H, Hthio), 4.56–4.86 (m, 4 H, CH2NO2, PhCH2), 4.35 (m, 1 H,
CHCHO), 4.05 (m, 1 H, CH) ppm. 13C NMR (300 MHz, CDCl3,
23 °C): δ = 202.7, 199.8 (CHO), 137.2, 136.3 (Cthio), 134.9 (CAr),
128.7 (CAr), 128.5 (CAr), 128.2 (CAr), 127.14 (Cthio), 126.8 (Cthio),
126.6 (Cthio), 83.9, 81.7 (CHCHO), 76.8, 76.7 (CH2NO2), 73.9, 73.7
(CH2O), 40.9, 40.2 (CHthio) ppm. HRMS: calcd. for C15H14NO4S
[M – H]– 304.064; found 304.064. HPLC (Chiralpak AS-H, iPrOH/
n-hexane = 3:97, 0.8 mL/min, λ = 217 nm): tR = 72.2 (anti-minor),
65.8 (anti-major), 58.5 (syn-major), 50.9 (syn-minor) min.
328.086. HPLC (Chiralpak AD-H, iPrOH/n-hexane
= 5:95,
0.75 mL/min, λ = 217 nm): tR = 32.6 (anti-minor), 28.5 (syn-
minor), 21.8 (anti-major), 20.2 (syn-major) min.
4-Nitro-3-phenyl-2-(2,2,2-trifluoroethoxy)butanal (12): 1H NMR
(300 MHz, CDCl3): δ = 9.51 (d, J = 1.2 Hz, 1 H, CHO), 9.46 (s, 1
H, CHO), 7.21–7.38 (m, 5 H, Ph), 4.96 (dd, J = 8.8, 13.4 Hz, 1 H,
CH2NO2), 4.85 (dd, J = 6.0, 13.5 Hz, 1 H, CF3CH2O), 4.77 (dd, J
= 8.4, 13.5 Hz, 1 H, CF3CH2O), 4.68 (dd, J = 6.5, 13.4 Hz, 1 H,
CH2NO2), 4.05–4.12 (m, 1 H, CHCHO), 3.82–3.88 (m, 1 H, PhCH)
ppm. 13C NMR (75 MHz, CDCl3): δ = 199.3 (CHO), 198.1 (CHO),
134.5 (CAr), 133.2 (CAr), 128.9 (CAr), 128.0 (CF3), 86.1, 84.8
(CHCHO), 75.7, 75.5 (CH2NO2), 68.6 (CF3CH2), 44.6, 44.5
(PhCH) ppm. HRMS: calcd. for C12H11F3NO4 [M – H]– 290.064;
found 290.036. HPLC (Chiralpak AD-H, iPrOH/n-hexane = 4:96,
0.45 mL/min, λ = 217 nm): tR = 95.6 (syn-minor), 87.3 (anti-
minor), 70.9 (syn-major), 66.3 (anti-major) min.
2-(tert-Butyldimethylsilyloxy)-4-nitro-3-phenylbutanal (13): 1H
NMR (300 MHz, CDCl3): δ = 9.56, 9.35 (d, J = 1.44 Hz, 1 H,
CHO), 7.29 (m, 5 H, Ph), 4.87 (dd, J = 8.3, 13.4 Hz, 1 H,
CH2NO2), 4.78 (m, 2 H, CHCHO), 4.68 (dd, J = 6.9, 13.4 Hz, 1
H, CH2NO2), 3.97 (m, 1 H, PhCH), 0.95, 0.92 [s, 9 H, C(CH3)3],
0.064, 0.057 (s, 3 H, 2 CH3) ppm. 13C NMR (300 MHz, CDCl3,
23 °C): δ = 202.5, 201.2 (CHO), 135.8, 134.2 (CAr), 129.0 (CAr),
128.4 (CAr), 128.0 (CAr), 79.5, 77.3 (CHCHO), 75.9, 75.0
(CH2NO2), 46.0 (PhCH), 25.7 [(CH3)3C], 25.6 [(CH3)3C], 18.1
(CH3) ppm. HRMS: calcd. for C16H24NO4Si [M – H]– 322.148;
found 322.148. HPLC (Chiralpak IC, iPrOH/n-hexane = 5:95,
0.5 mL/min, λ = 217 nm): tR = 44.8 (anti-minor), 22.9 (syn-major),
20.4 (anti-major), 16.9 (syn-minor) min.
1
Ethyl 3-(Benzyloxy)-2-(nitromethyl)-4-oxobutanoate (23): H NMR
(300 MHz, CDCl3): δ = 9.70 (s, 1 H, CHO), 9.66 (d, J = 0.8 Hz, 1
H, CHO), 7.30–7.42 (m, 5 H, Ph), 4.86 (dd, J = 7.4, 14.6 Hz, 1 H,
CH2NO2), 4.79 (d, J = 11.8 Hz, 1 H, PhCH2O), 4.63 (d, J =
11.8 Hz, 1 H, PhCH2O), 4.40 (dd, J = 6.0, 14.6 Hz, 1 H, CH2NO2),
4.20 (m, 2 H, CH2CH3), 4.06 (d, J = 3.5 Hz, 1 H, CHCHO), 3.85,
3.71 (ddd, J = 3.5, 6.0, 7.5 Hz, 1 H, EtO2CCH), 1.25, 1.23 (t, J =
7.2 Hz, 3 H, CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 200.3
(CHO), 199.2 (CHO), 169.1 (COOEt), 167.9 (COOEt), 135.0 (CAr),
135.9 (CAr), 128.8 (CAr), 80.1, 80.2 (CHCHO), 73.7 (PhCH2), 71.8,
70.9 (CH2NO2), 62.3 (OCH2CH3), 44.8, 43.7 (EtOOCCH), 13.9
(CH2CH3) ppm. HRMS: [M]+ calcd. for C17H17NO4 not visible.
HRMS: calcd. for C16H16NO3 [M – CO]– 299.113; found 299.993.
HPLC (Chiralcel OD-H, iPrOH/n-hexane = 10:90, 0.9 mL/min, λ
= 217 nm): tR = 43.2 (syn-minor), 29.2 (anti-minor), 24.7 (syn-
major), 19.8 (anti-major) min.
2-(Benzyloxy)-3-ethyl-4-methylpentanal (24): 1H NMR (300 MHz,
CDCl3): δ = 9.55, 9.44 (d, J = 1.2 Hz, 1 H, CHO), 7.35 (m, 9 H,
HAr), 4.74 (d, J = 11.6 Hz, 1 H, CH2NO2), 4.54 (d, J = 11.5 Hz, 1
H, CH2NO2), 4.48 (m, 2 H, PhCH2), 3.90, 3.87 (dd, J = 1.2, 4.2 Hz,
1 H,CHCHO), 2.69 (m, 1 H, iPrCH), 1.92 (m, 1 H, Me2CH), 0.97,
0.93 (d, J = 6.8 Hz, 2 CH3) ppm. 13C NMR (300 MHz, CDCl3): δ
= 202.8, 202.0 (CHO), 136.7 (CAr), 128.6 (CAr), 128.4 (CAr), 128.1
(CAr), 83.0, 82.2 (CHCHO), 73.8, 73.7 (CH2NO2), 73.3, 72.9
2-(Benzyloxy)-4-nitro-3-(4-trifluoromethylphenyl)butanal (20): 1H (CH2O), 45.2, 43.8 (iPrCH), 28.3, 27.1 (Me2CH), 19.9, 19.4 (2
NMR (300 MHz, CDCl3): δ = 9.59, 9.43 (d, J = 1.8 Hz, 1 H, CH3) ppm. HRMS: calcd. for C14H18NO4 [M – H]– 264.124; found
CHO), 7.58 (m, 2 H, HAr), 7.38 (m, 7 H, HAr), 4.83 (m, 1 H,
6434
264.124. HPLC (Chiralpak IC, iPrOH/n-hexane = 8:92, 0.5 mL/
www.eurjoc.org
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2010, 6430–6435